logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Invirsa announced it raised $2.86 Million in an amended filing from an offering of $2.86 Million

Aug 08, 20254 months ago

Amount Raised

$2.86 Million

Round Type

seed

ColumbusManufacturing

Company Information

Company

Invirsa

Location

1275 KINNEAR ROAD

Columbus, Ohio, United States

About

Invirsa is developing a small molecule (INV-102) that promotes both DNA repair and the innate immune response to infection and injury. These actions lead to enhanced wound healing associated with reductions in inflammation and viral replication. INV-102 has demonstrated unprecedented efficacy in animal models of ocular sulfur mustard gas injury. Sulfur mustard is a dangerous chemical weapon, and INV-102 is the first drug to show promise in preventing its long-term effects. There is no current FDA approved therapy for this injury.

Related People

2 contacts

Sign in to view contact details

Sign in to view contact details